Literature DB >> 22817709

Degradation of tau protein by autophagy and proteasomal pathways.

Yipeng Wang1, Eckhard Mandelkow.   

Abstract

Tau aggregates are present in several neurodegenerative diseases and correlate with the severity of memory deficit in AD (Alzheimer's disease). However, the triggers of tau aggregation and tau-induced neurodegeneration are still elusive. The impairment of protein-degradation systems might play a role in such processes, as these pathways normally keep tau levels at a low level which may prevent aggregation. Some proteases can process tau and thus contribute to tau aggregation by generating amyloidogenic fragments, but the complete clearance of tau mainly relies on the UPS (ubiquitin-proteasome system) and the ALS (autophagy-lysosome system). In the present paper, we focus on the regulation of the degradation of tau by the UPS and ALS and its relation to tau aggregation. We anticipate that stimulation of these two protein-degradation systems might be a potential therapeutic strategy for AD and other tauopathies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817709     DOI: 10.1042/BST20120071

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  70 in total

Review 1.  The Autophagy Lysosomal Pathway and Neurodegeneration.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

Review 2.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

3.  Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.

Authors:  Sarah N Fontaine; Jennifer N Rauch; Bryce A Nordhues; Victoria A Assimon; Andrew R Stothert; Umesh K Jinwal; Jonathan J Sabbagh; Lyra Chang; Stanley M Stevens; Erik R P Zuiderweg; Jason E Gestwicki; Chad A Dickey
Journal:  J Biol Chem       Date:  2015-04-11       Impact factor: 5.157

4.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

5.  Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.

Authors:  Elena E Korbolina; Nikita I Ershov; Leonid O Bryzgalov; Natalia G Kolosova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

6.  Tau and neuron aging.

Authors:  Jesus Avila; Elena Gomez de Barreda; Noemi Pallas-Bazarra; Felix Hernandez
Journal:  Aging Dis       Date:  2012-12-03       Impact factor: 6.745

Review 7.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

8.  Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.

Authors:  Elias Akoury; Marco D Mukrasch; Jacek Biernat; Katharina Tepper; Valery Ozenne; Eckhard Mandelkow; Martin Blackledge; Markus Zweckstetter
Journal:  Protein Sci       Date:  2016-03-24       Impact factor: 6.725

Review 9.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

10.  SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy.

Authors:  Sang-Won Min; Peter Dongmin Sohn; Yaqiao Li; Nino Devidze; Jeffrey R Johnson; Nevan J Krogan; Eliezer Masliah; Sue-Ann Mok; Jason E Gestwicki; Li Gan
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.